TrialScientific reports2025

Long-term gamma-aminobutyric acid (GABA) treatment fails to regain beta-cell function in longstanding type 1 diabetes in a randomized trial.

Henrik Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.